Publication Date
In 2024 | 0 |
Since 2023 | 0 |
Since 2020 (last 5 years) | 0 |
Since 2015 (last 10 years) | 0 |
Since 2005 (last 20 years) | 2 |
Descriptor
Neurological Impairments | 3 |
Animals | 2 |
Biochemistry | 2 |
Brain | 2 |
Drug Therapy | 2 |
Learning Processes | 2 |
Outcomes of Treatment | 2 |
Biology | 1 |
Brain Hemisphere Functions | 1 |
Chronic Illness | 1 |
Clinical Diagnosis | 1 |
More ▼ |
Source
Brain | 2 |
Learning & Memory | 2 |
Author
Bertolotto, Antonio | 1 |
Bozdagi, Ozlem | 1 |
Brown, Travis E. | 1 |
Capobianco, Marco | 1 |
Cocking, Davelle L. | 1 |
Fasano, A. | 1 |
Forquer, Melissa R. | 1 |
Gilli, Francesca | 1 |
Glass, Tracy | 1 |
Harding, Joseph W. | 1 |
Hoffmann, Francine | 1 |
More ▼ |
Publication Type
Journal Articles | 4 |
Reports - Research | 4 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Brown, Travis E.; Forquer, Melissa R.; Cocking, Davelle L.; Jansen, Heiko T.; Harding, Joseph W.; Sorg, Barbara A. – Learning & Memory, 2007
Persistent drug seeking/taking behavior involves the consolidation of memory. With each drug use, the memory may be reactivated and reconsolidated to maintain the original memory. During reactivation, the memory may become labile and susceptible to disruption; thus, molecules involved in plasticity should influence acquisition and/or…
Descriptors: Memory, Cocaine, Molecular Structure, Biochemistry
Nagy, Vanja; Bozdagi, Ozlem; Huntley, George W. – Learning & Memory, 2007
Matrix metalloproteinases (MMPs) are a family of extracellularly acting proteolytic enzymes with well-recognized roles in plasticity and remodeling of synaptic circuits during brain development and following brain injury. However, it is now becoming increasingly apparent that MMPs also function in normal, nonpathological synaptic plasticity of the…
Descriptors: Long Term Memory, Brain, Biochemistry, Learning Processes
Liuzzi, G. M.; Mastroianni, C. M.; Latronico, T.; Mengoni, F.; Fasano, A.; Lichtner, M.; Vullo, V.; Riccio, P. – Brain, 2004
The introduction of potent antiretroviral drugs for the treatment of patients with human immunodeficiency virus (HIV) infection has dramatically reduced the prevalence of HIV-associated neurological disorders. Such diseases can be mediated by proteolytic enzymes, i.e. matrix metalloproteinases (MMPs) and, in particular gelatinases, released from…
Descriptors: Sexually Transmitted Diseases, Drug Therapy, Outcomes of Treatment, Dementia
Gilli, Francesca; Bertolotto, Antonio; Sala, Arianna; Hoffmann, Francine; Capobianco, Marco; Malucchi, Simona; Glass, Tracy; Kappos, Ludwig; Lindberg, Raija L. P.; Leppert, David – Brain, 2004
Neutralizing antibodies (NAb) against interferon-[Beta] (IFN-Beta) develop in about a third of treated multiple sclerosis patients and are believed to reduce therapeutic efficacy of IFN-[Beta] on clinical and MRI measures. The expression of the interferon acute-response protein, myxovirus resistance protein A (MxA) is a sensitive measure of the…
Descriptors: Patients, Pathology, Metabolism, Chronic Illness